Literature DB >> 10586001

Development of guidelines for treatment of children with phenylketonuria: report of a meeting at the National Institute of Child Health and Human Development held August 15, 1995, National Institutes of Health, Bethesda, Maryland.

M R Seashore1, R Wappner, S Cho, F de La Cruz.   

Abstract

OBJECTIVE: To convene a small group of experts in diagnosis and management of PKU to discuss the following issues: the Subject Review of PKU management being performed by the American Academy of Pediatrics (AAP) Committee on Genetics (COG), the published British guidelines on PKU management, and the feasibility, suitability, and mechanism of developing PKU management guidelines for the United States.
METHODS: A 1-day meeting was held at the National Institutes of Health under the auspices of National Institute of Child Health and Human Development, convening experts in PKU diagnosis and management and members of the AAP/COG.
RESULTS: The group reviewed the published reports of outcomes of treatment of PKU and the British guidelines that were developed based on those data. It also reviewed the results of surveys of directors of clinics that manage PKU, parents of children with PKU, and young adults with PKU.
CONCLUSION: The group supported the efforts of the AAP/COG to perform this review of PKU management. The group concluded that significant issues need to be resolved to provide sufficient information to establish US guidelines for PKU management. The establishment of such guidelines is an important next step in PKU management in the United States.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10586001     DOI: 10.1542/peds.104.6.e67

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  Living with phenylketonuria: perspectives of patients and their families.

Authors:  C Bilginsoy; N Waitzman; C O Leonard; S L Ernst
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Behavioural factors related to metabolic control in patients with phenylketonuria.

Authors:  M R Crone; F J van Spronsen; K Oudshoorn; J Bekhof; G van Rijn; P H Verkerk
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria.

Authors:  M D Phillips; P McGraw; M J Lowe; V P Mathews; B E Hainline
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

4.  Dry storage of multiple reagent types within a paper microfluidic device for phenylalanine monitoring.

Authors:  Lael Wentland; Rachel Polaski; Elain Fu
Journal:  Anal Methods       Date:  2021-01-19       Impact factor: 2.896

5.  Development of a Whole Blood Paper-Based Device for Phenylalanine Detection in the Context of PKU Therapy Monitoring.

Authors:  Robert Robinson; Liam Wong; Raymond J Monnat; Elain Fu
Journal:  Micromachines (Basel)       Date:  2016-02-15       Impact factor: 2.891

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.